-
Snail Games Strengthens Publishing Portfolio Visibility at TwitchCon Through Strategic Partnership w
CULVER CITY, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital en...
资讯 · 2025-10-03 -
Constellation Brands Announces Retirement of Jim Bourdeau, EVP and Chief Legal Officer; Jeff LaBarge
ROCHESTER, N.Y., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today that Jim Bourdeau, Executive Vice President and Chief Le...
资讯 · 2025-10-03 -
跨越速运客服电话的背后:探寻跨越速运的智慧服务生态
一通跨越速运客服电话,如今正成为企业连接智慧物流服务生态的起点。在数字化浪潮席卷各行各业的背景下,物流行业的客户服务正经历着从单一热线到智慧化、集成化服务平台的深刻变革。作为行业的领军者,跨越速运通过...
资讯 · 2025-10-03 -
官宣!天工碳湾科创园,与“双碳”梦想共赴新程
“天工碳湾,既有效延续《天工开物》‘巧夺天工’的创新基因,更精准锚定新能源、新材料、生物医药等前沿赛道引育新质生产力,必将成为京津冀地区碳技术转化的‘加速器’、绿色产业集聚的‘强磁场’。” 欣承新...
资讯 · 2025-10-02 -
百卅学府 向新而行:天津大学校友企业联合会成立,共绘“天大+碳湾”生态新蓝图
百年学府,弦歌不辍育英才;创新引擎,破壁攻坚开新局;校友同心,聚势赋能兴伟业! 9月30日,天津大学科技创新与产业创新深度融合发展大会暨校友企业联合会成立大会在北洋园校区举行。本次大会以“创新策源·生态赋...
资讯 · 2025-10-02 -
百卅正青春 碳湾启新程!第七届“海棠杯”大赛全国总决赛圆满落幕
天津,2025年10月1日——第七届天津大学“海棠杯”校友创新创业大赛全国总决赛,在天津大学北洋园校区郑东图书馆圆满落幕。灵御智能机器人项目以笃行深耕冠冕,荣获全国总决赛特等奖。 七载砥砺 铸就双创“天大范...
资讯 · 2025-10-02 -
解决选择困难,国庆一天这样安排!
国庆假期的一天,既不想宅家浪费,又怕景点人山人海?选择困难症患者请看过来,一份完美的一日行程规划已送达,让你在上海市中心就能度过充实又轻松的一天! 潮流打卡与智能体验 目的地:上海环球港,金标大众「与众06淘金...
资讯 · 2025-10-02 -
Lantronix Edge AI Drone Solution Integrates Gremsy and Teledyne FLIR Platforms for Longer, More Effi
Strategic Collaboration positions Lantronix for long-term, high-margin growth in defense and commercial drone markets projected to reach $57.8B by 2030* IRVINE, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE)...
资讯 · 2025-10-02 -
nCino advances AI for mortgage lending with powerful new capabilities
New and expanded AI-driven features deliver faster borrower feedback, cleaner loan files and more capacity for loan officers WILMINGTON, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ:...
资讯 · 2025-10-02 -
AAVantgarde Announces FDA Orphan Drug Designation and UK CTA approval for AAVB-039 for the Treatment
AAVB-039 addresses the root cause of the disease, benefitting patients with any ABCA4 mutation AAVB-039 is currently being assessed in the CELESTE interventional clinical trial and we continue recr...
资讯 · 2025-10-02